ATE423573T1 - Azithromycin enthaltende stabilisierte suspensionen zur oralen anwendung - Google Patents

Azithromycin enthaltende stabilisierte suspensionen zur oralen anwendung

Info

Publication number
ATE423573T1
ATE423573T1 AT04252475T AT04252475T ATE423573T1 AT E423573 T1 ATE423573 T1 AT E423573T1 AT 04252475 T AT04252475 T AT 04252475T AT 04252475 T AT04252475 T AT 04252475T AT E423573 T1 ATE423573 T1 AT E423573T1
Authority
AT
Austria
Prior art keywords
oral use
suspensions containing
containing azithromycin
stabilized suspensions
stabilized
Prior art date
Application number
AT04252475T
Other languages
English (en)
Inventor
Steven William Collier
William John Curatolo
Barbara Alice Johnson
Brendan John Murphy
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of ATE423573T1 publication Critical patent/ATE423573T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT04252475T 2003-07-15 2004-04-28 Azithromycin enthaltende stabilisierte suspensionen zur oralen anwendung ATE423573T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48783703P 2003-07-15 2003-07-15
US10/636,013 US20050013835A1 (en) 2003-07-15 2003-08-06 Stable non-dihydrate azithromycin oral suspensions

Publications (1)

Publication Number Publication Date
ATE423573T1 true ATE423573T1 (de) 2009-03-15

Family

ID=33479339

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04252475T ATE423573T1 (de) 2003-07-15 2004-04-28 Azithromycin enthaltende stabilisierte suspensionen zur oralen anwendung

Country Status (16)

Country Link
US (1) US20050013835A1 (de)
EP (1) EP1498141B1 (de)
JP (1) JP4208759B2 (de)
KR (1) KR20060041229A (de)
AR (1) AR044647A1 (de)
AT (1) ATE423573T1 (de)
AU (1) AU2004255032A1 (de)
BR (1) BRPI0412541A (de)
CA (1) CA2464831A1 (de)
DE (1) DE602004019603D1 (de)
IL (1) IL172491A0 (de)
MX (1) MXPA06000272A (de)
NO (1) NO20060611L (de)
RU (1) RU2325149C2 (de)
TW (1) TW200501966A (de)
WO (1) WO2005004920A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2591744A1 (en) * 2004-12-21 2006-06-29 Pfizer Products Inc. Stable non-dihydrate azithromycin oral suspensions
US20090318375A1 (en) * 2005-06-08 2009-12-24 Hanmi Pharm Co., Ltd Crystalline Azithromycin L-Malate Monohydrate and Pharmaceutical Composition Containing Same
WO2011130707A2 (en) * 2010-04-15 2011-10-20 Chromocell Corporation Compounds, compositions, and methods for reducing or eliminating bitter taste
MX346673B (es) * 2010-04-15 2017-03-29 Chromocell Corp Compuestos, composiciones y metodos para reducir o eliminar el sabor amargo.
WO2013088274A1 (en) 2011-12-14 2013-06-20 Wockhardt Limited Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
JP5825088B2 (ja) * 2011-12-21 2015-12-02 ライオン株式会社 液体口腔用組成物
JP6456849B2 (ja) * 2013-03-01 2019-01-23 ハーキュリーズ・インコーポレーテッドＨｅｒｃｕｌｅｓ Ｉｎｃｏｒｐｏｒａｔｅｄ 高められた性能及び改善された加工性を有する医薬組成物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
MX12213A (es) * 1987-07-09 1993-05-01 Pfizer Metodo de preparacion de dihidrato de azitromicina cristalino
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
TW271400B (de) * 1992-07-30 1996-03-01 Pfizer
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
DE69524214T3 (de) * 1994-05-06 2008-05-15 Pfizer Inc. Azithromycin enthaltende arzneiverabreichungsformen mit gesteuerter wirkstoffabgabe
AUPP437698A0 (en) * 1998-06-30 1998-07-23 Baumgart, Karl Methods for treatment of coronary, carotid and other vascular disease
US6245903B1 (en) * 1998-08-21 2001-06-12 Apotex, Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
US6365574B2 (en) * 1998-11-30 2002-04-02 Teva Pharmaceutical Industries Ltd. Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
US6383527B1 (en) * 1999-03-04 2002-05-07 Nps Pharmaceuticals, Inc. Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a NSAID
US6703372B1 (en) * 1999-06-29 2004-03-09 Biochemie S.A. Macrolides
IT1313610B1 (it) * 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
IL141438A0 (en) * 2000-02-23 2002-03-10 Pfizer Prod Inc Method of increasing the bioavailability and tissue penetration of azithromycin
RU2188018C2 (ru) * 2000-06-20 2002-08-27 Нестерук Владимир Викторович Композиционный состав антибактериального лекарственного средства
DE60209704T2 (de) * 2001-05-22 2006-11-16 Pfizer Products Inc., Groton Neue kristallforme von azithromycin
US6861413B2 (en) * 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
WO2003032922A2 (en) * 2001-10-18 2003-04-24 Teva Pharmaceutical Industries Ltd. Stabilized azithromycin compositions
NZ532707A (en) * 2001-12-21 2006-07-28 Pfizer Prod Inc Directly compressible formulations of azithromycin
GB0214277D0 (en) * 2002-06-20 2002-07-31 Biochemie Gmbh Organic compounds
GB0224197D0 (en) * 2002-10-17 2002-11-27 Biochemie Gmbh Organic compounds

Also Published As

Publication number Publication date
BRPI0412541A (pt) 2006-09-19
AR044647A1 (es) 2005-09-21
RU2005140740A (ru) 2006-08-10
NO20060611L (no) 2006-04-10
IL172491A0 (en) 2006-04-10
DE602004019603D1 (de) 2009-04-09
EP1498141B1 (de) 2009-02-25
KR20060041229A (ko) 2006-05-11
JP4208759B2 (ja) 2009-01-14
EP1498141A1 (de) 2005-01-19
RU2325149C2 (ru) 2008-05-27
AU2004255032A1 (en) 2005-01-20
US20050013835A1 (en) 2005-01-20
MXPA06000272A (es) 2006-04-07
TW200501966A (en) 2005-01-16
WO2005004920A1 (en) 2005-01-20
CA2464831A1 (en) 2005-01-15
JP2005035973A (ja) 2005-02-10

Similar Documents

Publication Publication Date Title
EP1608283A4 (de) Dentales einweg-instrument
EP1686901A4 (de) Operationsinstrument
EP1627616A4 (de) Operationsinstrument
AU149492S (en) Writing instrument
EP1613235A4 (de) Endodontisches instrument
AU157802S (en) Writing instrument
GB2381243B (en) Writing instrument
AU155905S (en) Writing instrument
DE602004030570D1 (de) Schreibgerät
EP1680204A4 (de) Biologisches filter
DE502004002049D1 (de) Halteeinrichtung
AU155785S (en) Cleaning instrument
DE602004029481D1 (de) Keramikfilter
EP1619479A4 (de) Instrumenteinrichtung
DE602004019603D1 (de) Azithromycin enthaltende stabilisierte Suspensionen zur oralen Anwendung
DE602004021541D1 (de) Schreibinstrument
ITTO20040843A1 (it) Carica-tubetti per filatoi open end
AU156772S (en) Writing instrument
EP1607131A4 (de) Keramikfilter
EP1607129A4 (de) Keramikfilter
AU158273S (en) Writing instrument
EP1604718A4 (de) Keramikfilter
DE112004001801D2 (de) Haltevorrichtung
FI5917U1 (fi) Pidin
GB0312785D0 (en) Disposable chewable writing instrument

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties